Evidence map›Paper›PMID 35514735›Full record

ArticleRSC advances2019

A novel multi-reaction microdroplet platform for rapid radiochemistry optimization.

Alejandra Rios, Jia Wang, Philip H Chao, R Michael van Dam

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Journal of organic chemistry · 2021
    Article
  6. Optimization of Radiochemical Reactions using Droplet Arrays.Journal of visualized experiments : JoVE · 2021
    Article
  7. Article
  8. Article
  9. Green and efficient synthesis of the radiopharmaceutical [Reaction chemistry & engineering · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alejandra RiosCrump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA mvandam@mednet.ucla.edu.ORCID https://orcid.org/0000-0003-4881-5324
Jia WangCrump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA mvandam@mednet.ucla.edu.ORCID https://orcid.org/0000-0002-0070-1320
Philip H ChaoCrump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA mvandam@mednet.ucla.edu.ORCID https://orcid.org/0000-0001-5633-0269
R Michael van DamCrump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA mvandam@mednet.ucla.edu.ORCID https://orcid.org/0000-0003-2316-0173

Funding

Research Training in Biomedical PhysicsT32EB002101 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Michael F McNitt-Gray · 2003 to 2026
$5.3M
Commercialization of a Benchtop Radiosynthesizer for the Production of PET ProbesR44MH097271 · NIMH · SOFIE BIOSCIENCES, INC. · PI MOORE, MELISSA · 2013 to 2018
$3.8M
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancerR21CA212718 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2017 to 2018
$616k
NCI NIH HHS R21 CA212718NIBIB NIH HHS T32 EB002101NIMH NIH HHS R44 MH097271
6 · The paper itself

Abstract

During the development of novel tracers for positron emission tomography (PET), the optimization of the synthesis is hindered by practical limitations on the number of experiments that can be performed per day. Here we present a microliter droplet chip that contains multiple sites (4 or 16) to perform reactions simultaneously under the same or different conditions to accelerate radiosynthesis optimization.

Identifiers

PMID35514735
PMCPMC9065505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.